Expert consensus on diagnosis and treatment of end-stage liver disease complicated infection (2021 version).
10.3760/cma.j.cn501113-20220209-00061
- VernacularTitle:终末期肝病合并感染诊治专家共识（2021年版）
- Collective Name:Chinese Society of Infectious Diseases, Chinese Medical Association
- Publication Type:Journal Article
- Keywords:
Consensus;
Diagnosis;
End-stage liver disease;
Infection;
Treatment
- MeSH:
Consensus;
Disease Progression;
End Stage Liver Disease/complications*;
Humans
- From:
Chinese Journal of Hepatology
2022;30(2):147-158
- CountryChina
- Language:Chinese
-
Abstract:
End-stage liver disease (ESLD) is a life-threatening clinical syndrome with significantly increased mortality when the patients are complicated with infections. For patients with ESLD, infections can induce or aggravate the liver decompensation. In turn, infections are among the most common complication with the disease progression. Experts from Society of Infectious Diseases, Chinese Medical Association firstly formulated "Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infection" in July 2018, which is extensively revised based on clinical evidence of recent three years. This consensus summarizes the up-to-date knowledge and experiences across Chinese colleagues, intending to provide principles and wording procedures for clinicians to diagnose and treat ESLD patient complicated with infections.
